Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings
http://clinicaltrials.gov/ct2/show/NCT05158023
Oct 18, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next